Barclays Lowers Sotera Health (NASDAQ:SHC) Price Target to $13.00

Sotera Health (NASDAQ:SHC) had its price target reduced by stock analysts at Barclays from $15.00 to $13.00 in a research report issued to clients and investors on Tuesday,Benzinga reports. The firm currently has an “overweight” rating on the stock. Barclays‘s target price points to a potential upside of 16.03% from the company’s current price.

SHC has been the topic of a number of other reports. The Goldman Sachs Group upgraded shares of Sotera Health from a “neutral” rating to a “buy” rating and upped their target price for the company from $14.00 to $17.00 in a research report on Monday, May 5th. Piper Sandler cut their price objective on shares of Sotera Health from $15.00 to $13.00 and set a “neutral” rating on the stock in a report on Wednesday, April 23rd. Finally, Wall Street Zen cut shares of Sotera Health from a “buy” rating to a “hold” rating in a research note on Saturday, June 7th. Two equities research analysts have rated the stock with a hold rating and four have assigned a buy rating to the company’s stock. According to data from MarketBeat, the company has an average rating of “Moderate Buy” and an average target price of $16.00.

Sotera Health Stock Performance

NASDAQ SHC traded up $0.11 during midday trading on Tuesday, hitting $11.20. The company had a trading volume of 177,886 shares, compared to its average volume of 1,232,056. The firm has a fifty day simple moving average of $11.94 and a two-hundred day simple moving average of $12.43. Sotera Health has a fifty-two week low of $9.53 and a fifty-two week high of $17.08. The company has a quick ratio of 2.19, a current ratio of 2.46 and a debt-to-equity ratio of 5.55. The stock has a market cap of $3.18 billion, a price-to-earnings ratio of 140.02 and a beta of 1.87.

Sotera Health (NASDAQ:SHC) last released its quarterly earnings data on Thursday, May 1st. The company reported $0.14 EPS for the quarter, topping analysts’ consensus estimates of $0.12 by $0.02. Sotera Health had a net margin of 2.24% and a return on equity of 41.08%. The company had revenue of $254.52 million during the quarter, compared to the consensus estimate of $245.56 million. During the same period last year, the firm earned $0.13 EPS. The firm’s revenue for the quarter was up 2.6% compared to the same quarter last year. Equities analysts forecast that Sotera Health will post 0.61 earnings per share for the current fiscal year.

Hedge Funds Weigh In On Sotera Health

Institutional investors and hedge funds have recently modified their holdings of the business. Quarry LP acquired a new stake in Sotera Health during the fourth quarter worth approximately $28,000. Caitong International Asset Management Co. Ltd lifted its holdings in shares of Sotera Health by 3,690.1% during the 1st quarter. Caitong International Asset Management Co. Ltd now owns 2,691 shares of the company’s stock worth $31,000 after acquiring an additional 2,620 shares during the period. Blue Trust Inc. boosted its position in shares of Sotera Health by 504.0% during the 4th quarter. Blue Trust Inc. now owns 4,192 shares of the company’s stock worth $57,000 after acquiring an additional 3,498 shares in the last quarter. Summit Securities Group LLC bought a new position in Sotera Health in the first quarter valued at approximately $67,000. Finally, Farther Finance Advisors LLC raised its position in Sotera Health by 4,881.9% during the first quarter. Farther Finance Advisors LLC now owns 6,327 shares of the company’s stock valued at $70,000 after purchasing an additional 6,200 shares in the last quarter. 91.03% of the stock is currently owned by institutional investors and hedge funds.

Sotera Health Company Profile

Sotera Health Company engages in the provision of sterilization, lab testing, and advisory services in the United States and internationally. The company operates through three segments: Sterigenics, Nordion, and Nelson Labs. It provides mission-critical end-to-end sterilization services, including gamma and electron beam irradiation, and ethylene oxide processing, as well as designs, installs, and maintains gamma irradiation systems.